Literature DB >> 194044

Growth curve of an experimental solid tumor following radiotherapy.

L Norton, R Simon.   

Abstract

Because it has long been recognized that the growth of most untreated tumors is well described by Gompertzian or exponential growth curves but that the growth of treated tumors has never been well characterized mathematically, we developed and applied an equation that, while not dependent on restrictive assumptions or unmeasurable variables, was nevertheless capable of describing perturbed as well as unperturbed growth. For the 3964A rat hepatoma, a functional relationship between dose level of radiotherapy and growth-curve response was derived and used for predictive purposes. An implied relationship between tumor size and sensitivity to therapy and some clinical implications were examined.

Entities:  

Mesh:

Year:  1977        PMID: 194044     DOI: 10.1093/jnci/58.6.1735

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  36 in total

1.  An elementary approach to modeling drug resistance in cancer.

Authors:  Cristian Tomasetti; Doron Levy
Journal:  Math Biosci Eng       Date:  2010-10       Impact factor: 2.080

Review 2.  Evolution of acquired resistance to anti-cancer therapy.

Authors:  Jasmine Foo; Franziska Michor
Journal:  J Theor Biol       Date:  2014-03-25       Impact factor: 2.691

Review 3.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  Clinically relevant modeling of tumor growth and treatment response.

Authors:  Thomas E Yankeelov; Nkiruka Atuegwu; David Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Erin C Rericha; Vito Quaranta
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

Review 5.  Applications of mechanistic modelling to clinical and experimental immunology: an emerging technology to accelerate immunotherapeutic discovery and development.

Authors:  L V Brown; E A Gaffney; J Wagg; M C Coles
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

Review 6.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03

Review 7.  Breast cancer stem cells-research opportunities utilizing mathematical modeling.

Authors:  Rina Ashkenazi; Trachette L Jackson; Gabriela Dontu; Max S Wicha
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

8.  The impact of cell density and mutations in a model of multidrug resistance in solid tumors.

Authors:  James Greene; Orit Lavi; Michael M Gottesman; Doron Levy
Journal:  Bull Math Biol       Date:  2014-02-20       Impact factor: 1.758

9.  Pharmacokinetic-pharmacodynamic modeling of the anticancer effect of erlotinib in a human non-small cell lung cancer xenograft mouse model.

Authors:  Qiong Wu; Meng-yao Li; Han-qing Li; Chen-hui Deng; Liang Li; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2013-10-07       Impact factor: 6.150

10.  Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics.

Authors:  Philip Hahnfeldt; Lynn Hlatky; Giannoula Lakka Klement
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.